Shake Shack, Darden, Yum! 'Top Picks' for 2025 Says Oppenheimer
Analysts See Growth at Yum! Brands Units. In naming Yum! Brands one of its top picks, Oppenheimer analysts said that the ...
Oppenheimer raises Atlassian price target to $300, reiterates as a top pick
Oppenheimer raised the firm’s price target on Atlassian (TEAM) to $300 from $270 and keeps an Outperform rating on the shares ...
Oppenheimer downgrades BJ’s Restaurants, says model now in line with consensus
Oppenheimer downgraded BJ’s Restaurants (BJRI) to Perform from Outperform. The company’s underlying fundamentals appear solid, but the firm ...
Oppenheimer to Trump: Danyl McLauchlan on how tech titans & risk-takers are rocking politics
Today’s tech titans have a chutzpah reminiscent of the scientists behind the atomic bomb.
‘Killers Of The Flower Moon’ Should Have Won Best Picture, Not ‘Oppenheimer’
Apple / Universal. When Killers Of The Flower Moon first released in theaters and then later on Apple TV, I found the runtime ...
Oppenheimer Remains a Hold on Mosaic Co (MOS)
Oppenheimer analyst Kristen Owen maintained a Hold rating on Mosaic Co (MOS – Research Report) today. The company’s shares closed last Friday ...
Real challenges in getting behind Tesla's autonomous program, says Oppenheimer's Colin Rusch
Colin Rusch, Oppenheimer senior research analyst, joins 'Squawk Box' to discuss Tesla's deliveries data, Musk's relationship ...
Chris Nolan's Film 'The Odyssey' After 'Oppenheimer' Success—What We Know
Christopher Nolan's next film 'The Odyssey' is a mythic action epic shot across the world using brand new IMAX film ...
The Golden Globes Got a Little Weird With It
The 2025 winners were all over the map, portending a wide-open awards season.
Oppenheimer维持Jasper Therapeutics股票80美元目标价
周三，Oppenheimer重申了对Jasper Therapeutics (NASDAQ:JSPR)的"优于大市"评级和80.00美元的目标价，此举是在该公司报告了其BEACON研究的初步结果之后。这家市值约18亿美元的临床阶段生物技术公司正在开发用于治疗慢性疾病的创新疗法。
Oppenheimer重申iRhythm股票"跑赢大市"评级，强调战略互补性
周三，Oppenheimer将iRhythm Technologies (NASDAQ:IRTC)的目标价从之前的105美元上调至120美元，同时重申"跑赢大市"评级。此次调整是在12月底与iRhythm Technologies管理层会面后做出的。iRhythm Technologies是一家市值28亿美元的医疗技术公司。根据 InvestingPro ...